Affiliation:
1. Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, 364 Plantation Street, Worcester, Massachusetts 01605
Abstract
ABSTRACT
Human immunodeficiency virus type 1 (HIV-1) protease processes and cleaves the Gag and Gag-Pol polyproteins, allowing viral maturation, and therefore is an important target for antiviral therapy. Ligand binding occurs when the flaps open, allowing access to the active site. This flexibility in flap geometry makes trapping and crystallizing structural intermediates in substrate binding challenging. In this study, we report two crystal structures of two HIV-1 protease variants bound with their corresponding nucleocapsid-p1 variant. One of the flaps in each of these structures exhibits an unusual “intermediate” conformation. Analysis of the flap-intermediate and flap-closed crystal structures reveals that the intermonomer flap movements may be asynchronous and that the flap which wraps over the P3 to P1 (P3-P1) residues of the substrate might close first. This is consistent with our hypothesis that the P3-P1 region is crucial for substrate recognition. The intermediate conformation is conserved in both the wild-type and drug-resistant variants. The structural differences between the variants are evident only when the flaps are closed. Thus, a plausible structural model for the adaptability of HIV-1 protease to recognize substrates in the presence of drug-resistant mutations has been proposed.
Publisher
American Society for Microbiology
Subject
Virology,Insect Science,Immunology,Microbiology
Reference59 articles.
1. Andersson, H. O., K. Fridborg, S. Lowgren, M. Lalterman, A. Muhlman, M. Bjorsne, N. Garg, I. Kyarnstrom, W. Schaal, B. Classon, A. Karlen, U. H. Danielson, G. Ahlsen, U. Nillroth, L. Vrang, B. Oberg, B. Samuelsson, A. Hallberg, and T. Unge. 2003. Optimization of P1-P3 groups in symmetric and asymmetric HIV-1 protease inhibitors. Eur. J. Biochem.270:1756-1758.
2. Baldwin, E. T., T. N. Bhat, S. Gulnik, B. Liu, I. A. Topol, Y. Kiso, T. Mimoto, H. Mitsuya, and J. W. Erickson. 1995. Structure of HIV-1 protease with KNI-272, a tight-binding transition-state analog containing allophyenylnorstatine. Structure3:581-590.
3. Bally, F., R. Martinez, S. Peters, P. Sudre, and A. Telenti. 2000. Polymorphism of HIV type 1 Gag p7/p1 and p1/p6 cleavage sites: clinical significance and implications for resistance to protease inhibitors. AIDS Res. Hum. Retrovir.16:1209-1213.
4. Chou, K. 1996. Prediction of human immunodeficiency virus protease cleavage sites in proteins. Anal. Biochem.233:1-14.
5. Collaborative Computational Project Number 4. 1994. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. Sect. D Biol. Crystallogr.D50:760-763.
Cited by
48 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献